HUTCHMED Completes Enrollment in Phase II Registration Trial of Savolitinib for MET-Amplified Gastric Cancer

HUTCHMED (China) Limited (“HUTCHMED”)  announces that it has completed enrollment of the registration phase of its Phase II trial of savol...

April 22, 2025 | Tuesday | News
Gift of Life Biologics and Cellex Cell Professionals Celebrate Ongoing Success of Collaborative Partnership in Cell and Gene Therapy

Gift of Life Biologics, a leading supplier of high-quality cellular starting materials in the US, and Cellex Cell Professionals, a trusted Contract De...

April 08, 2025 | Tuesday | News
China Grants Breakthrough Therapy Designation to Innovent’s IBI363 for Hard-to-Treat Melanoma

Innovent Biologics, Inc.  a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the trea...

March 31, 2025 | Monday | News
FDA Accepts Roche’s sBLA for Gazyva®/Gazyvaro® (Obinutuzumab) as a Treatment for Lupus Nephritis

Roche announced  that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for...

March 06, 2025 | Thursday | News
Codoxo Unveils AI Data Health Integrity Agent to Streamline Claims Data Sharing for Healthcare Payers

Codoxo, the leading provider of artificial intelligence solutions in payment integrity and cost containment for healthcare payers, government agencies and ...

March 05, 2025 | Wednesday | News
Philadelphia’s Biotech Powerhouse: The City Fueling the United States of America’s Next Medical Breakthroughs

Philadelphia has long been known as a hub for history, education, and culture. But in recent years, the city has also solidified itself as a powerhouse i...

February 20, 2025 | Thursday | Reports
Nona Biosciences Partners with UAB to Advance B Cell Development Research through Innovative Licensing Agreement

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to I™),  announced a licensing agreement with ...

February 20, 2025 | Thursday | News
Gilead Sciences Announces FDA Acceptance of NDA for Lenacapavir as Twice-Yearly HIV Prevention Treatment

Gilead Sciences, Inc.  announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapa...

February 19, 2025 | Wednesday | News
Navi Medical Technologies' Neonav® ECG Tip Location System Receives FDA 510(k) Clearance for Pediatric Care

Navi Medical Technologies, a medical device company focused on pediatric healthcare innovation, proudly announces that its Neonav® ECG Tip Location Sys...

February 18, 2025 | Tuesday | News
Kessler Foundation Achieves Breakthrough in Spinal Cord Injury Treatment with First Epidural Spinal Stimulator Implant

The Tim and Caroline Reynolds Center for Spinal Stimulation at Kessler Foundation is proud to announce the implantation of a spinal cord epidural stim...

February 12, 2025 | Wednesday | News
Global Proteomics Breakthrough: UK Biobank and Thermo Fisher to Decode Disease

UK Biobank Pharma Proteomics Project aims to create a comprehensive map of disease-associated protein levels in the human body to advance biomarker...

January 13, 2025 | Monday | News
Revvity Secures FDA Clearance for EUROIMMUN’s Groundbreaking Free Testosterone Test

-Revvity, Inc.  announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for EUROIMMUN’s automated chemilu...

January 13, 2025 | Monday | News
Korean Researchers Pioneer Breakthrough Technique to Transform Fibroblasts into Functional Heart Cells

Korean scientists discover a groundbreaking method to transform ordinary fibroblasts into mature cardiomyocytes Researchers at Korea University have achie...

December 27, 2024 | Friday | News
HKBU and Shanghai Sixth People's Hospital Pioneer Breakthrough Treatment for Rare Bone Disease XLH

A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to School of Medicine at Shanghai Jiao ...

December 23, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close